Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
AERIE PHARMACEUTICALS INC (AERI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Aerie Pharmaceuticals, Inc. |
11/10/2022 |
SC 13G/A
| MORGAN STANLEY reports a 0.8% stake in AERIE PHARMACEUTICALS INC |
02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 2.3% stake in Aerie Pharmaceuticals, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| PFM Health Sciences, LP reports a 6% stake in Aerie Pharmaceuticals, Inc. |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
06/30/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
06/12/2020 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 1.8% stake in Aerie Pharmaceuticals, Inc. |
06/09/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 9.2% stake in Aerie Pharmaceuticals, Inc. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 11.9% stake in Aerie Pharmaceuticals, Inc. |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/28/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 14.6% stake in Aerie Pharmaceuticals, Inc. |
08/14/2019 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 11.2% stake in Aerie Pharmaceuticals, Inc. |
02/13/2019 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.9% stake in Aerie Pharmaceuticals, Inc. |
02/13/2019 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 8.6% stake in Aerie Pharmaceuticals, Inc. |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/23/2018 |
SC 13G/A
| Flynn James E reports a 8.6% stake in Aerie Pharmaceuticals, Inc. |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Flynn James E reports a 10% stake in Aerie Pharmaceuticals, Inc. |
02/13/2018 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 7.1% stake in Aerie Pharmaceuticals, Inc. |
02/13/2018 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 9.9% stake in Aerie Pharmaceuticals, Inc. |
|
|
|